NEW YORK ( TheStreet) -- CHANGE IN RATINGS
AthenaHealth upgraded at Leerink from Market Perform to Outperform, Leerink Swann said. Company is investing more in future growth.BB&T Corporation (BBT - Get Report) rated new Buy at UBS. $28 price target. Fee based business helps drive above peer revenue growth. Bank of New York (BK - Get Report) rated new Neutral at UBS. $20 price target. Limited vs. peers for capital deployment and negatively affected by the low rate environment. Carnival (CCL - Get Report) upgraded at HSBC from Neutral to Overweight, HSBC said. $38 price target. US demand remains strong. Discover (DFS - Get Report) upgraded at Stifel from Hold to Buy. $29 price target. Company continues to outperform its peers. Enbridge (ENB - Get Report) rated new Neutral at Citigroup. $36 price target. Full valuation at current levels. First Cash Financial (FCFS) upgraded at Sterne Agee from Underperform to Neutral, Sterne Agee said. $36 price target. Company is buying back more stock. Fleetcor (FLT) upgraded at Wells to Outperform, Wells Fargo said. Valuation call, as the company has solid earnings visibility. Green Dot (GDOT) rated new Outperform at Morgan Keegan. $36 price target. Target market remains underpenetrated. HollyFrontier (HFC) rated new Buy at Citigroup. $25 price target. Modest upside from current valuation. Kroger (KR) rated new Hold at Cantor. Valuation call, based on a $24 price target. Linear Technology (LLTC) upgraded at Oppenheimer from Perform to Outperform at Oppenheimer. $36 price target. Order patterns have stabilized. Microsemi (MSCC) rated new Equal-weight at Evercore. $18 price target. Company has a lot of debt and lacks organic growth potential. Northern Trust (NTRS) rated new Market Perform at Wells Fargo. Valuation call. Discover (DFS - Get Report) upgraded at Guggenheim from Neutral to Buy, Guggenheim said. $27 price target. Estimates also boosted, given higher share buybacks. PNC Financial (PNC) rated new Neutral at UBS. $57 price target. Transition into Basel III and current low rate environment. Transocean (RIG) upgraded at Global Hunter from Reduce to Neutral. Valuation call, based on a $43 price target. Research in Motion (RIMM) downgraded at BMO from Outperform to Market Perform, BMO Capital said. $15 price target. New strategic moves could destroy more value. State Street (STT) rated new Buy at UBS. $46 price target. Best positioned among group to withstand the current environment. Safeway (SWY) rated new Sell at Cantor. $16 price target. Earnings are likely to decline in 2012. Sysco (SYY) rated new Hold at Cantor. $29 price targe. Expenses could remain high, given continued ERP investment. Transdigm (TDG) rated new Neutral at Goldman. $105 price target. Growth in the commercial aftermarket appears to be slowing. Thoratec (THOR) rated new Neutral at Goldman. $33 price target. Company could face increased competition in the coming quarters. US Bancorp (USB) rated new Buy at UBS. $32 price target. Optimal banking model for current environment and a proven track record of superior revenue generation. Wells Fargo (WFC - Get Report) rated new Neutral at UBS. $27 price target. Strong franchise, but waiting for headwinds to subside. Yahoo! (YHOO - Get Report) downgraded at Evercore from Overweight to Equal-weight, Evercore Partners said. Valuation call, based on an $18 price target.
STOCK COMMENTS / EPS CHANGESAccenture (ACN) estimates reduced at Morgan Stanley through 2014, Morgan Stanley said. Company had a cautious tone on the conference call. Overweight rating and $66 price target. Adobe Systems (ADBE) numbers raised at UBS. Shares of ADBE now seen reaching $34, according to UBS. Estimates also increased on strong Q4 and low bar for 2012. Buy rating. Adobe estimates increased at Morgan Stanley through 2013. Cloud services and digital marketing should continue to drive growth. Equal-weight rating. Adobe Systems estimates lowered at Jefferies through 2012. Business model transition year. Buy rating. Aetna (AET) numbers raised at Jefferies. Shares of AET now seen reaching $55. Estimates also raised on better visibility into next year's trends. Buy rating. AthenaHealth (ATHN - Get Report) numbers lowered at Jefferies. Shares of ATHN now seen reaching $50, Jefferies said. Estimates also lowered on rich valuation. Hold rating. Coca-Cola Enterprises (CCE) estimates lowered at UBS through 2012, UBS said. Incorporating French soda tax. Maintain $30 price target and Buy rating. Covidien (COV) target upped at Goldman to $53, Goldman Sachs said. Pharma spin-off should help unlock value. Buy rating. Flowserve (FLS) estimates, target cut at BMO. FLS estimates were reduced through 2013, BMO Capital said. Company lowered its guidance. Outperform rating and new $135 price target. Flowserve numbers lowered at Jefferies. Shares of FLS now seen reaching $113, Jefferies said. Estimates also lowered on light guidance. Buy rating. General Mills (GIS) target boosted at Credit Suisse. Shares of GIS now seen reaching $41. Company is seeing better pricing power. Neutral rating and $41 price target. Goldman Sachs (GS) numbers cut at JMP. Shares of GS now seen reaching $158, according to JMP Securities. Estimates also reduced, given slower client activity across the board. Outperform rating. Juniper Networks (JNPR - Get Report) numbers lowered at UBS. Shares of JNPR now seen reaching $20.50, according to UBS. Estimates also lowered on tougher capex environment. Morgan Stanley (MS) numbers lowered at JMP. Shares of MS now seen reaching $26, according to JMP Securities. Estimates also cut, given the MBIA settlement and lower client activity. Outperform rating. Nordson (NDSN) estimates, target reduced at BMO. Shares of NDSN now seen reaching $45, according to BMO Capital. Estimates also cut, given slower expected global growth. Market Perform rating. Pier 1 (PIR) numbers raised at Credit Suisse. Shares of PIR now seen reaching $15. Estimates also increased, given increased productivity. Neutral rating. Philip Morris (PM) added to Priority Stock List at Wells Fargo. Company is a market leader and has a solid 4.4% dividend yield. Research in Motion (RIMM) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Another tough quarter. Perform rating.
Research In Motion numbers lowered at UBS. Shares of RIMM now seen reaching $15.50, according to UBS. Estimates also lowered on disappointing guidance. Neutral rating. Research in Motion numbers cut at Goldman. Shares of RIMM now seen reaching $14, according to Goldman Sachs. Estimates also reduced, given higher operating costs. Neutral rating. Research in Motion target lowered at Jefferies. Shares of RIMM now seen reaching $13.50, Jefferies said. Delayed QNX handsets acknowledged. Underperform rating. Solutia (SOA) numbers lowered at Jefferies. Shares of SOA now seen reaching $22, Jefferies said. Estimates also lowered as the investor day reset the bar. Buy rating. United Technologies (UTX) numbers lowered at Jefferies. Shares of UTX now seen reaching $90. Estimates also lowered on conservative 2012 outlook. Buy rating. Viacom (VIA) estimates, target lowered at UBS. Shares of VIA now seen reaching $54. Estimates also lowered on ongoing soft ratings and a continued slow scatter market. Buy rating. ViroPharma Incorporated (VPHM) estimates lowered at Jefferies to $32, Jefferies said. Vancocin exclusivity requires more caution. Hold rating. Western Union (WU) estimates lowered at Jefferies through 2012, Jefferies said. IRS settlement announced. Buy rating. >To submit a news tip, email: email@example.com.
Follow TheStreet on Twitter and become a fan on Facebook.